Page last updated: 2024-09-05

methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and thromboxane a2

methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate has been researched along with thromboxane a2 in 1 studies

Compound Research Comparison

Studies
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Trials
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Recent Studies (post-2010)
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Studies
(thromboxane a2)
Trials
(thromboxane a2)
Recent Studies (post-2010) (thromboxane a2)
16005,617224429

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piper, PJ; Yaacob, HB1

Other Studies

1 other study(ies) available for methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and thromboxane a2

ArticleYear
Interactions of platelet activating factor, thromboxane A2 and leukotrienes in guinea-pig heart.
    Progress in clinical and biological research, 1989, Volume: 301

    Topics: Anaphylaxis; Animals; Azepines; Cyclooxygenase Inhibitors; Guinea Pigs; Heart; In Vitro Techniques; Indomethacin; Leukotrienes; Lipoxygenase Inhibitors; Naphthoquinones; ortho-Aminobenzoates; Platelet Activating Factor; Thromboxane A2; Triazines; Triazoles

1989